库珀医疗CooperCompanies（COO）2025财年10-K年度报告「NYSE」（英文版）（110页）.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549_FORM 10-K_ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934FOR THE FISCAL YEAR ENDED OCTOBER 31,2025TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934FOR THE TR

2、ANSITION PERIOD FROM TOCOMMISSION FILE NO.001-08597_THE COOPER COMPANIES,INC.(Exact name of registrant as specified in its charter)_Delaware94-2657368(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)6101 Bollinger Canyon Road,Suite 500San Ramon,Califor

3、nia 94583(Address of principal executive offices)(Zip Code)(925)460-3600(Registrants telephone number,including area code)_Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading SymbolName of each exchange on which registeredCommon Stock,$0.10 par valueCOONasdaq Global

4、Select Market Securities registered pursuant to Section 12(g)of the Act:None_ Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 o

5、r 15(d)of the Act.Yes No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during thepreceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has b

6、een subject to such filing requirements for the past 90days.Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorte